- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.44 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 14 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 10 residues within 4Å:- Chain A: S.407, S.468, C.469, S.479, K.480, C.499, N.501, S.503, Y.524, D.526
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.524
- Hydrogen bonds: A:C.469, A:N.501, A:D.526, A:D.526
NAG.6: 8 residues within 4Å:- Chain A: S.537, M.566, N.568, F.569, K.571, N.572, T.590, S.591
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.537, A:T.590
NAG.7: 4 residues within 4Å:- Chain A: R.674, R.695, N.698, R.701
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:R.674
- Hydrogen bonds: A:R.695, A:N.698
NAG.8: 5 residues within 4Å:- Chain A: N.391, S.393, M.394, K.396, H.493
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.391, A:K.396
- Water bridges: A:N.391
NAG.9: 3 residues within 4Å:- Chain A: Q.509, N.512, S.514
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.512, A:S.514
- Water bridges: A:T.510, A:N.512
NAG.10: 4 residues within 4Å:- Chain A: K.306, G.309, D.310, N.339
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.306
- Water bridges: A:G.309, A:N.339
NAG.11: 6 residues within 4Å:- Chain A: E.632, D.634, N.657, S.659, T.681, N.705
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.657
- Water bridges: A:E.632
NAG.14: 10 residues within 4Å:- Chain B: S.407, S.468, C.469, S.479, K.480, C.499, N.501, S.503, Y.524, D.526
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:Y.524
- Hydrogen bonds: B:C.469, B:N.501, B:D.526, B:D.526
- Water bridges: B:S.468, B:Y.470
NAG.15: 8 residues within 4Å:- Chain B: S.537, M.566, N.568, F.569, K.571, N.572, T.590, S.591
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:S.537, B:T.590
- Water bridges: B:R.592, B:E.595
NAG.16: 4 residues within 4Å:- Chain B: Q.509, N.512, S.514, E.515
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.512, B:N.512, B:S.514, B:E.515
- Water bridges: B:Q.509
NAG.17: 5 residues within 4Å:- Chain B: N.391, S.393, M.394, K.396, H.493
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.391, B:K.396
- Water bridges: B:S.393, B:H.493
NAG.18: 4 residues within 4Å:- Chain B: K.306, G.309, D.310, N.339
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:K.306
NAG.19: 7 residues within 4Å:- Chain B: T.601, E.631, E.632, K.656, N.657, T.681, N.705
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:N.657, B:N.657, B:T.681, B:N.705
- Water bridges: B:E.631, B:N.657
NAG.20: 3 residues within 4Å:- Chain B: E.671, R.674, N.698
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.674, B:N.698
- 2 x ZWV: (3S)-3-{[5-amino-1-({3-methoxy-5-[1-(oxan-4-yl)piperidin-4-yl]pyridin-2-yl}methyl)-1H-pyrazolo[4,3-d]pyrimidin-7-yl]amino}hexan-1-ol(Non-covalent)
ZWV.12: 22 residues within 4Å:- Chain A: T.510, D.533, L.535, H.536, G.562, I.563, T.564
- Chain B: Y.242, N.243, F.327, F.329, E.330, L.331, Q.332, V.333, Y.334, G.357, V.359, T.384, F.386, K.410
- Ligands: SO4.13
15 PLIP interactions:10 interactions with chain B, 5 interactions with chain A- Hydrophobic interactions: B:F.329, B:F.329, B:Y.334, B:V.359, B:F.386
- Hydrogen bonds: B:Y.242, B:Q.332, A:T.564, A:T.564
- Water bridges: B:Y.242, A:T.510, A:D.533
- pi-Stacking: B:F.386, B:F.386
- Salt bridges: A:D.533
ZWV.21: 23 residues within 4Å:- Chain A: Y.242, N.243, F.327, F.329, E.330, L.331, Q.332, V.333, Y.334, G.357, V.359, T.384, F.386, K.410
- Chain B: T.510, D.533, L.535, H.536, G.562, I.563, T.564, H.565
- Ligands: SO4.22
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.329, A:F.329, A:Y.334, A:V.359, A:F.386
- Hydrogen bonds: A:Y.242, B:T.564, B:T.564
- Water bridges: A:Y.242
- pi-Stacking: A:F.386, A:F.386
- Salt bridges: B:D.533
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.13: 5 residues within 4Å:- Chain A: N.512, H.536, S.537, T.538
- Ligands: ZWV.12
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.537, A:T.538
- Water bridges: A:H.536
- Salt bridges: A:H.536
SO4.22: 4 residues within 4Å:- Chain B: L.535, H.536, S.537
- Ligands: ZWV.21
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.535
- Water bridges: B:S.537
- Salt bridges: B:H.536
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- He, L. et al., Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-02-07
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.44 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 14 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x ZWV: (3S)-3-{[5-amino-1-({3-methoxy-5-[1-(oxan-4-yl)piperidin-4-yl]pyridin-2-yl}methyl)-1H-pyrazolo[4,3-d]pyrimidin-7-yl]amino}hexan-1-ol(Non-covalent)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- He, L. et al., Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology. Acs Med.Chem.Lett. (2024)
- Release Date
- 2024-02-07
- Peptides
- Toll-like receptor 7: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B